The Medicine Maker

Business & Regulation Standards & Regulation Profession Vaccines Advanced Medicine Regulation & Standards Business & Trends Cell & Gene

Peter Marks Resigns from FDA

April 1, 2025

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

3 min read

Business & Regulation Standards & Regulation Regulation & Standards Business & Trends

Vaccines and Autism: Perpetuating a Populist Agenda

April 1, 2025

Rumours claim that a well-known vaccine skeptic has been appointed to lead study on links between vaccines and autism.

3 min read

Vaccines and Autism: Perpetuating a Populist Agenda

Business & Regulation Digital Technologies Clinical Trials Facilities & Equipment Development & Clinical

AI, Big Data, and Digital Disruption

March 31, 2025

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

7 min read

Business & Regulation Standards & Regulation Business Practice Trends & Forecasts Small Molecules Regulation & Standards Business & Trends Small Molecules

The Future of the NIH

March 27, 2025

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

2 min read

Discovery & Development Drug Discovery Trends & Forecasts Drug Discovery Research News Business & Trends

The Glycomic Revolution

March 27, 2025

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D

2 min read

Manufacture Advanced Medicine Contract Manufacturing Services Business Practice Cell & Gene Outsourcing Technology & Manufacturing Business & Trends

Building a Resilient CGT Workforce

March 26, 2025

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to ensure they are investing in training and mentorship.

3 min read

Manufacture Quality & Compliance Supply Chain Regulation & Standards Supply Chain

Innovating Pharmaceutical Packaging

March 25, 2025

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements, offering expert insights into the future of pharmaceutical packaging.

3 min read

Business & Regulation Business Practice Marketing Standards & Regulation Small Molecules Business & Trends Regulation & Standards Small Molecules

Calling Out Misleading Information

March 24, 2025

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

2 min read

Business & Regulation Advanced Medicine Standards & Regulation Trends & Forecasts Cell & Gene Regulation & Standards Business & Trends

We Need to Talk About CRISPR

March 21, 2025

Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.

4 min read

Manufacture Technology and Equipment Small Molecules Facilities & Equipment Technology & Manufacturing Small Molecules

The Myths and Reality of Hot Melt Extrusion

March 20, 2025

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

6 min read

The Myths and Reality of Hot Melt Extrusion

Interview Drug Discovery Development & Clinical Formulation Drug Delivery Bioprocessing Small Molecules Cell & Gene Facilities & Equipment Outsourcing Packaging Supply Chain Regulation & Standards Industry News Research News Sitting Down With Innovation Awards Business & Trends Technology & Manufacturing Biopharma Future of Pharma Latest Blog

Mar

Peter Marks Resigns from FDA

Vaccines and Autism: Perpetuating a Populist Agenda

AI, Big Data, and Digital Disruption

The Future of the NIH

The Glycomic Revolution

Building a Resilient CGT Workforce

Innovating Pharmaceutical Packaging

Calling Out Misleading Information

We Need to Talk About CRISPR

The Myths and Reality of Hot Melt Extrusion

Recommended

Browse by Topics

Explore

Featured Topics

Issues

Topics

News & Blogs

Community & Awards

Mar

Peter Marks Resigns from FDA

Vaccines and Autism: Perpetuating a Populist Agenda

AI, Big Data, and Digital Disruption

The Future of the NIH

The Glycomic Revolution

Building a Resilient CGT Workforce

Innovating Pharmaceutical Packaging

Calling Out Misleading Information

We Need to Talk About CRISPR

The Myths and Reality of Hot Melt Extrusion

Recommended

Browse by Topics